NPPA fixes retail prices of 14 formulations, check out details
New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 14 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).
The notice states that in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Following are the details
Sl. No | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Amlodipine +, Valsartan Tablet (Valembic 80 AM) | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine USP 5mg, Valsartan USP 80mg Tablet | 1 Tablet | M/s Vapicare pharma Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 2.10 |
2 | Amlodipine +, Valsartan Tablet (Valembic 160 AM) | Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine USP 5mg, Valsartan USP 160mg Tablet | 1 Tablet | M/s Vapicare pharma Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 3.24 |
3 | Paclitaxel (Protein Bound Particles) for Injectable Suspension (Nabtoxol) | Each vial contains: Paclitaxel 100mg Human albumin | 1 Vial | M/s Panacea Biotec Ltd. / M/s Mylan Pharmaceuticals Pvt. Ltd. | 11115.39 |
4 | Telmisartan + Chlorthalidone Tablet | Each uncoated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Limited | 7.41 |
5 | Glimepiride + Metformin + Voglibose Tablet (TRIVOGO 2/0.3 Mg) | Each uncoated bilayered tablet contains: Glimepiride IP 2mg, Metformin Hydrochloride IP 500mg (As SR form) Voglibose IP 0.3mg | 1 Tablet | M/s Windlas Biotech Limited / M/s Alembic Pharmaceuticals Ltd. | 9.39 |
6 | Etoricoxib + Paracetamol Tablet | Each film coated tablet contains: Etoricoxib IP 60mg , Paracetamol IP 325mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 5.14 |
7 | Sofosbuvir + Velpatasvir Tablets | Each film coated tablet contains: Sofosbuvir IH 400mg, Velpatasvir IH 100mg | 28’s Tablets | M/s Hetero Labs Ltd. / M/s Torrent Pharmaceuticals Ltd. | 15625.00 |
8 | Atorvastatin + Clopidogrel Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Limited | 8.394 |
9 | Atorvastatin + Clopidogrel Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Limited | 10.596 |
10 | Rosuvastatin + Aspirin + Clopidogrel Capsule | Each hard gelatine capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastation 20mg (As pellets) Aspirin IP 75mg (As enteric coated pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd../ M/s Intas Pharmaceuticals Limited | 18.00 |
11 | Ferrous Ascorbate + Folic Acid Suspension | Each 5ml of suspension contains: Ferrous Ascorbate eq. to elemental Iron 30mg, Folic Acid IP 550mcg In a flavoured Syrupy base. | 1 ML | M/s Innova Captab Pvt. Ltd. / M/s Intas Pharmaceuticals Limited | 0.647 |
12 | Bortezomib Injection | Each vial contains: Bortezomib IP 3.5mg Injection | 1 Vial | M/s Intas Pharmaceuticals Limited | 12500.00 |
13 | Teneligliptin + Metformin HCl Tablet | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg Metformin HCl 500mg (SR) | 1 Tablet | M/s Windlas Biotech Limited and marketed by M/s Abbott India Limited | 9.62 |
14 | Teneligliptin + Metformin HCl Tablet | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg Metformin HCl 1000mg (SR) | 1 Tablet | M/s Windlas Biotech Limited and marketed by M/s Abbott India Limited | 10.87 |
The manufacturers of above said scheduled formulations shall furnish a quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form – III of Schedule – II of the DPCO, 2013 through IPDMS.
Any manufacturer intending to discontinue production of said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule – II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
The manufacturers not complying with the ceiling price and notes specified shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Below is the attachment for the same.
http://www.nppaindia.nic.in/ceiling/press27feb18/Formulation_Prices(14).pdf
Medical Dialogues had earlier reported that NPPA had fixed the ceiling prices of 09 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).
Read also: 9 more formulations including Methylprednisolone Inj under Price Ceiling: NPPA order
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd